Skip to main content

Albuterol sulfate and Ipratropium Bromide Inhalation Solution Shortage

Last Updated: June 2, 2024
Status: Current

Products Affected - Description
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 69097-0840-64 - discontinued
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 69097-0840-53 - discontinued
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 69097-0173-64
Reason for the Shortage
    • Cipla did not provide a reason for the shortage.
    • Mylan has albuterol and ipratropium inhalation solution available.
    • Nephron is shipping albuterol and ipratropium inhalation solution regularly. Nephron states demand has recently increased for product.
    • Ritedose has albuterol and ipratropium inhalation solution available.
    • Sun Pharma has albuterol and ipratropium inhalation solution available.
Available Products
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 69097-0840-87
    • Albuterol sulfate and ipratropium bromide inhalation solution, Cipla USA, 3 mg/ 0.5 mg, 3 mL 30 vials per carton/5 vials per foil pouch NDC 69097-0173-53
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 30 vials per carton/30 vial per foil pouch NDC 00378-9671-30
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 60 vials per carton/30 vial per foil pouch NDC 00378-9671-60
    • Albuterol sulfate and ipratropium bromide inhalation solution, Mylan (Viatris), 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 00378-9671-93
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 00487-0201-01
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 30 vials per carton/5 vials per foil pouch NDC 00487-0201-03
    • Albuterol sulfate and ipratropium bromide inhalation solution, Nephron Pharmaceuticals Corporation, 3 mg / 0.5 mg, 3 mL 60 vials per carton/5 vials per foil pouch NDC 00487-0201-60
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 60 vials per carton/30 vial per foil pouch NDC 76204-0600-60
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 30 vials per carton/30 vial per foil pouch NDC 76204-0600-30
    • Albuterol sulfate and ipratropium bromide inhalation solution, Ritedose, 3 mg / 0.5 mg, 3 mL 30 vials per carton/1 vial per foil pouch NDC 76204-0600-01
    • Albuterol sulfate and ipratropium bromide inhalation solution, Sun Pharma, 3 mg / 0.5 mg, 3 mL 30 vials per carton NDC 47335-0756-49
    • Albuterol sulfate and ipratropium bromide inhalation solution, Sun Pharma, 3 mg / 0.5 mg, 3 mL 60 vials per carton NDC 47335-0756-52

Estimated Resupply Dates

    • Cipla has albuterol and ipratropium 3 mL inhalation solution in 60 count available in limited supply.

Updated

Updated June 2, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created January 13, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer